Patients with endocrine disease

Hormone therapy users or those who had been pregnant in the last 12 months before the diagnosis

Patients with a negative expression for estrogen and/or progesterone receptors

Women with a history of thromboembolism

Patients who had previously undergone any treatment for breast cancer

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy